Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-08

Clinical Trial Update: Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

View source ↗

Summary

Clinical trial update on withdrawing antiviral therapy after long-term treatment for chronic hepatitis B; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative | Status: COMPLETED